Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
IVIG
•
General Rheumatology
Are serologies reliable in a patient undergoing workup for autoimmune disease who is receiving IVIG for a different indication?
Related Questions
Should the age at which patients transition from pediatric to adult care differ depending on the disease diagnosis?
What is your approach to differentiating tender spots (as in fibromyalgia) and enthesitis (as in axSpA)?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
What is your approach to counseling patients regarding re-initiation of anti-TNF therapy after completion of treatment for non-disseminated pulmonary histoplasmosis?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
In patients with diffuse scleroderma and symptomatic lower extremity venous insufficiency would you recommend treatment with endovenous laser/ablation?
How do you approach management of adult patients with CVID and sarcoid-like syndrome?
Do you prefer celecoxib over a nonselective NSAID in patients with chronic kidney disease?
Would you ever consider retreatment with an antiresorptive medication in a patient with a remote history of atypical fracture attributed to an oral bisphosphonate?
